Table 1. CHDs and associated genetic syndromes.
Genetic abnormality | Genetic test | Type of CHD | % Affected by CHD | Associated genes |
---|---|---|---|---|
Trisomy 21 | FISH CMA |
ASD, VSD, AVCD, TOF | 40–50 | 3rd copy of chromosome 21; unbalanced translocation |
Trisomy 13 | FISH CMA |
ASD, PDA, VSD, pulmonary atresia with CHD | 60–80 | 3rd copy of chromosome 13; unbalanced translocation |
Trisomy 18 | FISH CMA |
ASD, VSD, PDA, CoA, bicuspid aortic valve, complex CHD | 60–80 | 3rd copy of chromosome 18 |
Monosomy X (Turner syndrome) | FISH CMA |
CoA, BAV, AS, partial anomalous pulmonary, venous return, HLHS | 23–50 | Partial or incomplete absence of 1 X chromosome 45X |
DiGeorge syndrome (chromosome 22q11.2 deletion) | FISH, CMA | IAA type B, aortic arch anomalies, truncus, arteriosus, TOF | 70–75 | 22q11.2 deletion |
Noonan syndrome | Noonan gene panel | PS, hypertrophic CM, ASD | 70–80 | RAS-MAPK pathway (KRAS, SOS1, RAF1, NRAS, BRAF, SCHOC2, CBL, RIT1) |
Alagille syndrome | CMA | PS, TOF | 90 | JAG1, NOTCH2 |
Holt-Oram syndrome | Molecular testing | HCM | 75 | TBX5 |
Abbreviations: AVCD, atrioventricular canal defect; ASD, atrial septal defect; BAV, bicuspid aortic valve; CHD, congenital heart disease; CM, cardiomyopathy; CMA, chromosomal microarray; CoA, coarctation of the aorta; HCM, hypertrophic cardiomyopathy; PDA, patent ductus arteriosus; PS, pulmonic stenosis; TOF, tetralogy of Fallot; VSD, ventricular septal defect.